ArticleFrontiers in endocrinology2025
Dynamic trajectories of the triglyceride-glucose index link to all-cause hospital mortality in patients with hypertension and kidney failure: a multicenter study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease and hypertension form a vicious cardiorenal cycle, exacerbating metabolic dysfunction and mortality. The triglyceride-glucose (TyG) index, a surrogate for insulin resistance, has shown prognostic value in cardiovascular and renal diseases. Previous research analyzed single-timepoint TyG, ignoring longitudinal trajectories during hospitalization. We aimed to investigate TyG trajectories and their association with hospital mortality in patients with hypertension and kidney failure (KF). Methods: Patients diagnosed with hypertension and KF were retrospectively retrieved from MIMIC-IV and a private dataset. Patients were clustered into four TyG trajectory groups using K-means clustering. A novel time-weighted average TyG (WATyG) metric was developed to quantify cumulative metabolic exposure. Logistic regression, restricted cubic spline (RCS) models, and subgroup analyses examined associations between TyG dynamics and mortality. Results: A total of 2,038 patients from MIMIC-IV and 1,266 from a private dataset were analyzed, with mortality rates of 28.41% and 7.03%, respectively. Four TyG trajectories were identified: rapidly increasing (Cluster 1), rapidly decreasing (Cluster 2), persistent high (Cluster 3), and stable low (Cluster 4). Clusters 1 and 3 had significantly higher mortality rates than Clusters 2 and 4 (all P<0.001). In MIMIC-IV, mortality rates were 38.8%/35.0% for Clusters 1/3 versus 22.6%/22.7% for Clusters 2/4, while the private dataset showed rates of 18.5%/7.6% (Clusters 1/3) versus 5.5%/4.0% (Clusters 2/4). Using Cluster 1 as reference in the adjusted model, Cluster 2 (OR 0.546, P=0.007) and Cluster 4 (OR 0.492, P<0.001) showed lower mortality risks in MIMIC-IV, with consistent trends in the private dataset. WATyG was linearly associated with an increased risk of mortality (OR 1.505, P<0.001 in MIMIC-IV). Conclusions: Dynamic TyG trajectories are linked to mortality risk in patients with hypertension and KF. WATyG improves risk stratification via cumulative metabolic exposure. Longitudinal TyG monitoring holds potential value for optimizing clinical decision-making by enabling continuous assessment of metabolic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.